Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nusinersen mitigates neuroinflammation in severe spinal muscular atrophy patients
Tommaso Nuzzo, Rosita Russo, Francesco Errico, et al.
Communications Medicine (2023) Vol. 3, Iss. 1
Open Access | Times Cited: 21

Showing 21 citing articles:

Sex and Gender Differences in Neurodegenerative Diseases: Challenges for Therapeutic Opportunities
Annalisa Bianco, Ylenia Antonacci, Maria Liguori
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6354-6354
Open Access | Times Cited: 37
Balancing RNA processing and innate immune response: Possible roles for SMN condensates in snRNP biogenesis
Hiroshi Maita, Shinichi Nakagawa
Biochimica et Biophysica Acta (BBA) - General Subjects (2025), pp. 130764-130764
Closed Access | Times Cited: 1
Dysregulation of innate immune signaling in animal models of spinal muscular atrophy
Eric L. Garcia, Rebecca E. Steiner, Amanda C. Raimer, et al.
BMC Biology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 6
Molecular Biomarkers for the Diagnosis, Prognosis, and Pharmacodynamics of Spinal Muscular Atrophy
Marija Babić, Maria Banović, Ivana Berečić, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 15, pp. 5060-5060
Open Access | Times Cited: 13
Identifying novel response markers for spinal muscular atrophy revealed by targeted proteomics following gene therapy
Devesh C. Pant, Sumit Verma
Gene Therapy (2025)
Closed Access
Experience of Nusinersen treatment in Advanced Spinal Muscular Atrophy Type 1: Characteristics of Late Responders with Delayed Treatment Efficacy
Sachi Tokunaga, Hideki Shimomura, Takuya Horibe, et al.
European Journal of Paediatric Neurology (2025) Vol. 54, pp. 171-177
Closed Access
Dysregulated balance of D- and L-amino acids modulating glutamatergic neurotransmission in severe spinal muscular atrophy
Amber Hassan, Raffaella di Vito, Tommaso Nuzzo, et al.
Neurobiology of Disease (2025), pp. 106849-106849
Open Access
Glial Cells in Spinal Muscular Atrophy: Speculations on Non-Cell-Autonomous Mechanisms and Therapeutic Implications
Andrej Belančić, Tamara Janković, Elvira Meni Maria Gkrinia, et al.
Neurology International (2025) Vol. 17, Iss. 3, pp. 41-41
Open Access
RNase H1 counteracts DNA damage and ameliorates SMN-dependent phenotypes in aDrosophilamodel of Spinal Muscular Atrophy
Livia Scatolini, Lucia Graziadio, Damiano Guerrini, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Cell-mediated cytotoxicity within CSF and brain parenchyma in spinal muscular atrophy unaltered by nusinersen treatment
I‐Na Lu, Phyllis F. Cheung, Michael Heming, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 3
Insights into spinal muscular atrophy from molecular biomarkers
Xiaodong Xing, Xinzhu Liu, Xiandeng Li, et al.
Neural Regeneration Research (2024) Vol. 20, Iss. 7, pp. 1849-1863
Open Access | Times Cited: 3
SMN deficiency perturbs monoamine neurotransmitter metabolism in spinal muscular atrophy
Valeria Valsecchi, Francesco Errico, Valentina Bassareo, et al.
Communications Biology (2023) Vol. 6, Iss. 1
Open Access | Times Cited: 8
Cytokines in cerebrospinal fluid as a prognostic predictor after treatment of nusinersen in SMA patients
Xi Cheng, Yanan Li, Ya-Bei Fan, et al.
Clinical Neurology and Neurosurgery (2024) Vol. 244, pp. 108462-108462
Open Access | Times Cited: 2
Proteomics profiling and machine learning in nusinersen-treated patients with spinal muscular atrophy
Chiara Panicucci, Eray Şahin, Martina Bartolucci, et al.
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access | Times Cited: 1
Profiling neuroinflammatory markers and response to nusinersen in paediatric spinal muscular atrophy
Qiang Zhang, Ying Hong, Chiara Brusa, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Neuroinflammation in spinal muscular atrophy
Heather Wood
Nature Reviews Neurology (2023)
Closed Access | Times Cited: 3
IL-1Ra and CCL5, but not IL-10, are promising targets for treating SMA astrocyte-driven pathology
Reilly L. Allison, Mya Suneja, Megan LaCroix, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
Current and emerging targeted therapies for spinal muscular atrophy
Yuliya Lakhina, Nicholas M. Boulis, Anthony Donsante
Expert Review of Neurotherapeutics (2023) Vol. 23, Iss. 12, pp. 1189-1199
Closed Access | Times Cited: 2
An early Transcriptomic Investigation in Adult Patients with Spinal Muscular Atrophy Under Treatment with Nusinersen
Maria Liguori, Annalisa Bianco, Alessandro Introna, et al.
Journal of Molecular Neuroscience (2024) Vol. 74, Iss. 4
Open Access
Genetic Variability in Oxidative Stress, Inflammatory, and Neurodevelopmental Pathways: Impact on the Susceptibility and Course of Spinal Muscular Atrophy
Maruša Barbo, Blaž Koritnik, Lea Leonardis, et al.
Cellular and Molecular Neurobiology (2024) Vol. 44, Iss. 1
Open Access
Dysregulation of innate immune signaling in animal models of Spinal Muscular Atrophy
Eric L Garcia, Rebecca E. Steiner, Amanda C. Raimer, et al.
(2023)
Open Access
Page 1

Scroll to top